Medical Treatment of Silent Myocardial Ischemia

Heart Disease

Volumn 1, Issue 5, 1999, Pages 272-278

  Cohn, Peter F ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGINA PECTORIS; ARTICLE; CHRONIC DISEASE; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS;

ANGINA PECTORIS; CHRONIC DISEASE; HEMODYNAMICS; HUMAN; MYOCARDIAL ISCHEMIA; PROGNOSIS;

EID: 0033224420     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Droste C. Roskamm H. Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol 1983;81:164-172.
2. Falcone C, Guasti L, Ochan M, Codega S, Tortorici M, Angoli L, et al. Beta-endorphins during coronary angioplasty in patients wirh silent or symptomatic myocardial ischemia. J Am Coll Cardiol 1993;22:1614-1620.
3. Oldroy KG, Harvey K, Gray CE, Beastall GH, Cobbe SM. Beta-endorphin release in patients after spontaneous and provoked acute myocardial ischemia. Br Heart J 1992;67:230-235.
4. Marchant B, Umachandran V, Wilkinson P, Medbak S, Kopelman PG, Timmis AD. Re-examination of the role of endogenous opiates in silent myocardial ischemia. J Am Coll Cardiol 1994;23:645-651.
5. Crea H, Pupita G, Galassi AR, El-Tamimi H, Kaski JC, Davies G, Maseri A. Role of adenosine in pathogenesis of anginal pain. Circulation 1990;81:164-172.
6. Sigward U, Gerbic M, Payot M, Goy J-J, Essingcr A, Fischer A. Ischemic events during coronary artery balloon occlusion. In, Rutishauswer W, Roskamm H (eds.): Silent Myocardial Ischemia. Berlin: Springer-Verlag, 1984;29-36.
7. Hirzel HO, Leutwyler R, Krayenbuehl HP. Silent myocadial ischemia: hemodynamic changes during dynamic exercise in patients with proved coronary artery despite absence of angina pectoris. J Am Coll Cardiol 1985;6:275-284.
8. Cohn PF, Brown EJ, Wynne J, Holman BL, Atkins HL. Global and regional left ventricular ejection fraction abnormalities during exercise in patients with silent myocardial ischemia. J am Coll Cardiol 1983;1:931-933.
9. Iskandrian AS, Hakki AH. Left ventricular function in patients with coronary heart disease in the presence of absence of angina pectoris during exercise radionuclide ventriculography. Am J Coll Cardiol 1984;53:1239-1243.
10. Froehicher VF, Thompson AJ, Longo MR Jr., Triebwasser JH, Lancaste MC. Value of exercise testing for screening asymptomatic men for latent coronary artery disease. Prog Cardiovasc Dis 1976;16:265-276.
11. Thaulow E, Erikssen J, Sandik L, Erikssen G, Joregensen L, Cohn PF. Initial clinical presentation of cardiac disease in asymptomatic men with silent myocar dial ischemia and angiographically documented coronary artery disease: the Oslo ischemia study. Am J Cardiol 1993;72:629-633.
12. Fazzini PF, Prati PL, Rovelli F, Antoniucci D, Menghini F, Seccareccia F, Menotti A. Epidemiology of silent myocardial ischemia in asymptomatic middle-aged men (the ECCIS Project). Am J Cardiol 1993;72:1383-1388.
13. Fleg JL, Gerstenblith G, Zonderman AB, Becker LC, Weisfeldt ML, Costa PT, LaKatta EG. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers. Circulation 1990;81:428-436.
14. Cohn PF. Silent myocardial ischemia. Ann Intern Med 1988;109:312-317.
15. Bolognese L, Rossi L, Sarasso G, Prando MD, Bongo AS, Dellavesa P, Rossi P. Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: clinical and prognostic significance. J Am Coll Cardiol 1992;19:953-959.
16. Shang SJ, Pepine CJ. Transient asymptomatic ST-segment depression during daily activity. Am J Cardiol 1977;139:396-402.
17. McLenachan JM, Weidinger FF, Barry J, Yeung A, Nabel EG, Rocco MB, Selwyn AP. Relations between heart rate, ischemia, and drug therapy during daily life in patients with coronary artery disease, Circulation 1991;83:1263-1270.
18. Rautaharju PM, Prineas RJ, Eifler WJ, Furberg CD, Neaton JD, Crow RS, et al. Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: multiple risk factor intervention trial experience. J Am Coll Cardiol 1986;8:1-10.
19. Gordon DJ, Elelund L-G, Karon JM, Probsfield JL, Rubenstein C, Sheffield LT, Weissfeld L. Predictive value of the exercise test for mortality in North American men: the lipid research clinics mortality follow-up study. Circulation 1986;2: 252-261.
20. Hedblad B, Mollder SJ, Svensson K, Hanson BS, Isacsson S, Janzon L, et al. Increased mortality in men with ST segment depression during 24 h ambulatory long-term ECG recording: results from prospective population study "Men born in 1914," from Malmo, Sweden. Eur Heart J 1989;10:149-158.
21. Theroux P, Waters DD, Halphen C, Debaiseux JC, Mizgala HF. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med 1979; 301:341-345.
22. DeBelder M, Skehan D, Pumphrey C, Khan B, Evans S, Rothman M, Mills P. Identification of a high risk subgroup of patients with silent ischaemia after myocardial infarction: a group for early therapeutic revascularization? Br Heart J 1990;63:145-150.
23. Gottlieb SO, Gottlieb SH, Achuff SC, Baumgardner R, Mellits ED, Weisfeldt ML, Gertstenblith G. Silent ischemia on Holter monitoring predicts mortality in high risk post infarction patients. JAMA 1988;259:1030-1035.
24. Falcone C, deServi S, Pom E. Clinical significance of exercise-induced silent myocardial ischemia in patients with coronary artery disease. J Am Coll Cardiol 1989;14:1175-1180.
25. Deedwania PC, Carbaja EV. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 1990;81:748-756.
26. Imperi GA, Lambert CR, Coy K, Lopea L, Pepine CJ. Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory paitents with coronary artery disease. Am J Cardiol 1987;60:519-524.
27. Tuzcu EM, Nisanci Y, Simpfendorger C, Dorosti K, Franco I, Hollman J, Whitlow P. Percutaneous transluminal coronary angioplasty in silent ischemia. Am Heart J 1990;119:797-801.
28. Anderson HV, Talley JD, Black AJR, Roubin GS, Doublas JS Jr, King SB III. Usefulness of coronary angioplasty in asymptomatic patients. Am J Cardiol 1990;65:35-39.
29. Ruberman W, Crow R, Rosenberg CR, Rautaharju PM, Shore RE, Pasternack BS. Intermittent ST depression and mortality after myocardial infarction. Circulation 1992;85:1440-1446.
30. Dubiel JP, Moczurad KW, Bryniarski L. Efficacy of a single dose of slow-release isosorbide dintrate in the treatment of silent or painful myocardial ischemia in stable angina pectoris. Am J Cardiol 1992;69:1156-1161.
31. Frishman W, Charlap S, Kimmel B, Teicher M, Cinnamon J, Allen L, Strom J. Diltiazmen, nifedipine and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance and the ambulatory electrocardio graphic ST segment. Circulation 1988;77:774-786.
32. Dargie HJ, Lynch PG, Krikler DM, Harris L, Krikle S. Nifedipine and propranolol: a beneficial drug interaction. Am J Med 1981;71:676-682.
33. Cohn PF, Vetrovec GW, Nesto R, Gerbet GR, and the Total Ischemia Awareness Program Investigators. The nifedipine-total ischemia awareness program: a national survey of painful and painless myocardial ischemia including results of antiischemic therapy. Am J Cardiol 1989;63:534-539.
34. Parmley WW, Nesto RW, Singh BN, Deanfield J, Gottlieb SO, and the N-Cap Study Group. Attentuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. J Am Coll Cardiol 1992;19:1380-1389.
35. Davies RF, Habibi H, Klinke WT, Dessain P, Nadeau C, Phaneuf DC, et al. Effect of amlodipine, atenolol and their combinations on myocardial ischemia during treadmill exercise and ambulatory monitoring. J Am Cardiol 1995;25: 619-625.
36. Egstrup K. Randomized double-blind comparison of metoprolol, nifedipine, and their combination in chronic stable angina: effects on total ischemic activity and heart rate at onset of ischemia. Am Heart J 1988;115:220-226.
37. Quyyumi AA, Crake T, Wright CM, Mockus LJ, Fox KM. Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate. Br Heart J 1987;57:505-5511.
38. Parker JD, Testa ZMA, Jimena AH, Tofler GH, Muller JE, Parker JO, Stone PH. Morning increase in ambulatory ischemia in patients with stable coronary artery disease: importance of physical activity and increased cardiac demand. Circulation 1994;89:604-614.
39. Willich SN, Pohjola Sintonen S, Bhatia SJ, Shook TL, Tofler GH, Muller JH, et al. Suppression ot silent ischemia by metoprolol without alteration of platelet aggregability in patients with coronary artery disease. Circulation 1989;79: 557-565.
40. Mahony C. Effect of aspirin on myocardial ischemia. Am J Cardiol 1989;64: 387-389.
41. Nyman I, Larsson H, Wallentin L, and the RISK Study Group in Southeast Sweden. Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischemia. Lancet 1992;340:497-501.
42. Lim R, Dyke L, Dymond DS. Effect on prognosis ot abolition of exercise induced painless myocardial ischemia by medical therapy. Am J Cardiol 1992; 69:733-735.
43. Pepine CJ, Geller NL, Knatterud GL, Bourassa MG, Chairman BR, Davies RF, et al, for rhe ACIP Investigators. The asymptomatic cardiac ischemia pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long term trial. J Am Coll Cardiol 1944;24:1-10.
44. Knatterud GL, Bourassa MG, Pepine CJ, Geller NL, Sopko G, Chairman BR, et al, for the ACIP Investigators. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12 week results of asymptomatic cardiac ischemia (ACIP) study. J Am Coll Cardiol 1994;24:11-20.
45. Rodgers WJ, Bourassa, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR, et al, for the ACIP Investigators. Asymptomatic cardiac ischemia pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol 1955;26:594-605.
46. Bourassa MG, Pepine CJ, Forman SA, Rogers WJ, Dyrda I, Stone PH, et al, for the ACIP Investigators. Asymptomatic cardiac ischemia pilot (ACIP) study: effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia. J Am Coll Cardiol 1955;26:606-614.
47. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N, et al, for the ACIP Investigators. Asymptomatic cardiac ischemia pilot (ACIP) study for two year follow-up. Circulation 1997;95:2037-2043.
48. Pepine CJ, Cohn PF, Deedwania PAC, Gibson RS, Handberg E, Hill JA, et al, for the ASIST Study Group. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life: the atenolol silent ischemia study. Circulation 1994;90:762-768.
49. Dargie HJ, Flord I, Fox KM, on behalf of the TIBET study group. Total ischemic burden European trial (TIBET). Eur Heart J 1996;17:104-112.
50. Mangan DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Eng J Med 1996;335: 1713-1763.